- Details
- Hits: 1545
While it's a drug that's widely considered as ‘safe’, nitrous oxide can cause serious harm.
Medical professionals are calling for tighter restrictions on the sale of nitrous oxide gas cartridges, colloquially known as ‘nangs’, due to potentially serious harm for users including lasting neurological damage. Nitrous oxide or ‘laughing gas’ is normally used by dentists and medical professionals to provide sedation and pain relief to patients undergoing minor procedures. It’s also a food additive, used to aerate whipped cream, and sold in gas cartridges online and in convenience stores.
An increasing number of Australians are also using nitrous oxide recreationally, inhaling the gas to produce a fleeting feeling of euphoria and excitement. Many people who use the drug consider it to be relatively harmless, but according to experts from the National Drug and Alcohol Research Centre (NDARC) at UNSW Sydney, this is far from the case.
‘Nangs’ are increasingly popular – Among people who regularly use ecstasy and/or other illicit stimulants, surveyed by NDARC as part of the Ecstasy and Related Drugs Reporting System (EDRS), nitrous oxide use has jumped in recent years. From 2003 to 2015, approximately one-quarter of the group reported nitrous oxide use in the past six months. This proportion doubled to 50 per cent in 2018 and has remained at a similar level since. The frequency and quantity of nitrous oxide use among these participants has remained relatively low and stable over time.
Less is known about nitrous oxide use in the general population, but this also appears to be increasing over time. The Australian Institute of Health and Welfare (AIHW) reported in their National Drug Strategy Household Survey that past year use of inhalants, which included nitrous oxide, increased from 0.4 per cent of participants in 2001, to 1.7 per cent in 2019.
Acute dangers and long-term neurological effects – With increased use of nitrous oxide among some groups, there have been increased reports of harm. For example, in a recent study of 60 emergency departments across New South Wales, presentations related to nitrous oxide use have increased from less than 10 in 2012 to more than 60 in 2018.
According to Professor Shane Darke from NDARC, recreational nitrous oxide use has the potential for harmful effects in the short and longer term.
“If you’re in a medical situation and you’re being given nitrous oxide… it’s mixed with oxygen. These people aren’t doing that. What they’re doing is covering their faces and inhaling pure gas,” Professor Darke said.
“Now the problem with that is there’s no oxygen. You run the risk of asphyxia.”
While using nitrous oxide, people are also at risk of entering a delirious state, according to Professor Darke. “They can be a risk to themselves and others. There have been spontaneous suicides and accidents.”
Emergency physicians have also started noticing people presenting with jerking and odd movements after using nitrous oxide. That’s not just an unsteady gait due to intoxication – rather, a sign of significant nerve damage.
“[Nitrous oxide] interferes with the absorption of Vitamin B12. This leads to neurological damage and eventually in severe cases, spinal degeneration,” Professor Darke said. “In an acute case you might be able to reverse that with infusions of B12. But in chronic cases it’s irreversible.”
It’s important to note people with neurological symptoms have been heavy users of nitrous oxide, inhaling the gas every day for months and consuming hundreds of canisters at a time. More research is needed to understand the effects of light to moderate use, which may still carry risk of nerve damage.
For complete article go to Nitrous oxide – not a laughing matter | UNSW Newsroom
Also See
- Details
- Hits: 1325
Chronic use of e-cigarettes, commonly known as vaping, can result in progressive small airway obstruction and asthma-like symptoms such as shortness of breath and chest pains, according to researchers at Massachusetts General Hospital (MGH). In the first study to microscopically evaluate the pulmonary tissue of e-cigarette users for chronic disease, the team found in a small sample of patients fibrosis and damage in the small airways, similar to the chemical inhalation damage to the lungs typically seen in soldiers returning from overseas conflicts who had inhaled mustard or similar types of noxious gases.
In addition, three of the four patients had evidence of mild emphysema consistent with their former combustible cigarette smoking history, though researchers concluded this was distinct from the findings of constrictive bronchiolitis seen in the patient cohort.
Because the same type of lung damage was observed in all patients, as well as partial improvement in symptoms after e-cigarette usage was stopped, researchers concluded that vaping was the most likely cause after thorough evaluation and exclusion of other possible causes. "Our investigation shows that chronic pathological abnormalities can occur in vaping exposure," says senior author David Christiani, MD, a physician investigator at Mass General Research Institute. "Physicians need to be informed by scientific evidence when advising patients about the potential harm of long-term vaping, and this work adds to a growing body of toxicological evidence that nicotine vaping exposures can harm the lung."
The study was published in New England Journal of Medicine Evidence.
- Details
- Hits: 1485
A flagrant black market is selling vapes and e-cigarettes containing nicotine to young people in plain sight of authorities and in contravention of the law, exposing a new generation to the highly addictive substance.
Nearly all store-bought vapes contain the chemical nicotine, despite not stating so on the packaging, threatening to undo decades of public health campaigning on the dangers of smoking.
Health experts said the true toll of vaping may not be known for years as convenience stores and tobacconists continue to sell vapes with near impunity.
Tobacconists in inner Sydney sold The Oz vapes without asking for proof-of-age identification or a valid prescription for nicotine e-cigarettes, which is a requirement by law.
None of the vapes said they contained nicotine on the packaging and only one tobacconist said that the vape they sold The Oz contained nicotine, an IGET Shion Pod. They did not ask for a prescription.
Independent testing by the University of Wollongong (UOW) confirmed all but one of the four store-bought vapes – a strawberry lychee flavoured One Vape – contained the highly addictive chemical.
Dr Celine Kelso said the UOW’s School of Chemistry has tested hundreds of vapes. She said all contained nicotine except for the one supplied by The Oz For more go to Almost all vapes contain nicotine: health effects still unclear
Also see
- Details
- Hits: 1740
A new paper argues that excitement has veered into misinformation—and scientists should be the ones to set things straight.
CONCLUSIONS: On the basis of the change in depression scores on the QIDS-SR-16 at week 6, this trial did not show a significant difference in antidepressant effects between psilocybin and escitalopram in a selected group of patients. Secondary outcomes generally favored psilocybin over escitalopram, but the analyses of these outcomes lacked correction for multiple comparisons. Trial of Psilocybin versus Escitalopram for Depression | NEJM
IN APRIL 2021, a widely anticipated paper in the field of psychedelics dropped. The study, a small trial run at Imperial College London and published in The New England Journal of Medicine, investigated the use of psilocybin, the active ingredient in magic mushrooms, to treat depression. Led by Robin Carhart-Harris, who now directs the Neuroscape Psychedelics Division at the University of California, San Francisco, the research compared psilocybin with a standard antidepressant. The findings were somewhat lackluster: it found that the psychedelic was only marginally better than traditional treatments at relieving depression.
Back in 2017, Rosalind Watts, an author on that paper and a former clinical lead for the trial at Imperial, had given a TEDx talk on the power of psilocybin to treat depression, prompted by the time she had spent working on the study. In the talk, she shared her belief that psilocybin could “revolutionize mental health care.” But in February of this year, Watts published a Medium piece in which she expressed regret at her initial unbridled enthusiasm. “I can’t help but feel as if I unknowingly contributed to a simplistic and potentially dangerous narrative around psychedelics; a narrative I’m trying to correct,” she wrote.
“I just reflected on how I myself had got caught up in the black and white of like, ‘This is wonderful,’” she says today. “Now having been through that trial … I’m much more neutral and agnostic.”
Scientists’ unwillingness to accept criticism makes Corlett pessimistic about the future of psychedelic research. “Science is meant to be somewhat adversarial. It’s not meant to be presided over by a single group of people,” he says. “I’m still open and excited about the possibilities, but I think this kind of breathless rush to translation and to a conclusion is really dangerous.”
And in an ethically murky turn, for those in the field who have begun to dabble in the corporate side of psychedelics, hyping up findings has become of obvious interest. Declaring conflicts of interest is standard practice in academia, and for good reason: Would you trust a paper that declared that spending more time on Instagram makes you happy if the lead author was receiving money from Meta? But that happens on a regular basis in psychedelic research; many in the field have accepted board positions or consulting fees for the ever-expanding number of psychedelic companies. That means “it’s literally a financial incentive to hype the results,” says Yaden. Watts agrees: “I think for research to be truly solid and not hyping things, it needs to be separated out from the interests of the companies who have stuff to gain.” (For complete article go to WIRED )
- Expectation, Excitation, Subjectivity, Idiosyncrasy, Placebo, and the Psychedelic Micro-dosing Experiment
- Exploring the gateway hypothesis of e-cigarettes and tobacco: a prospective replication study among adolescents…
- Vaping cannabinoid acetate leads to formation of deadly gas – New Study
- Vaping and GERD – Further Harms Inflicted!